via National Human Genome Research Institute
Researchers from the University of Sheffield have discovered a new gene therapy pathway that has the potential to protect us against serious life-limiting diseases such as cancer and dementia
Researchers from the University of Sheffield have discovered a new gene therapy pathway that has uncovered an important regulatory mechanism to keep our genome healthy. This pathway has the potential to protect us against serious life-limiting diseases such as cancer and dementia.
Cancer and neurodegeneration are two major health challenges currently affecting the population, and they constitute two sides of the same coin – one is caused by uncontrolled cell proliferation due to genome damage, and the other is caused by excessive genome damage that causes cell death. This new pathway impacts both and offers new therapeutic opportunities to help the fight against disease.
Published in Nature Communications, the research found that when cells in our body read DNA to build proteins, they often make mistakes that can damage our genome, causing disease such as cancer and dementia. However, by investigating how cells fix damage in the DNA to keep us healthy, scientists have discovered the benefits of three proteins working together as a team. The three proteins, called USP11, KEAP1 and SETX, receive instructions from their coach to direct their function in space and time with remarkable harmony, to keep our DNA healthy.
By understanding how cells protect themselves from these mistakes and thus preventing diseases, scientists are able to modify the behaviour of these proteins to promote the health and wellbeing of people.
Findings from this study will enable scientists to develop diagnostic tests and drugs to target one or more of the proteins in the pathway for the early detection and treatment of certain types of cancer and neurological disease. Developing new drugs to regulate the level of one or more of these proteins is expected to offer new treatments for cancer and dementia.
The findings are important and significant, this is because we are now at the stage where we could make drugs to control this modification. This would be useful in killing cells, which is what we do when we treat elderly people for cancer. The other application would be to reduce the level of genome damage, which could be beneficial for other ageing associated disorders like dementia.
Original Article: New gene therapy pathway could protect us from cancer and dementia
More from: University of Sheffield
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Gene therapy pathway
- Tune Therapeutics Launches with Pioneering Epigenomic Control Platform to Master Gene Networks, Treat Broad Range of Diseaseson December 2, 2021 at 2:00 am
Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched today with its powerful and ...
- Study could lead to new strategies to prevent or slow Alzheimer's diseaseon December 1, 2021 at 6:37 pm
A gene mutation linked to Alzheimer's disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine.
- Targeting the brain’s immune cells may help prevent or treat Alzheimer’s diseaseon December 1, 2021 at 11:01 am
A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine. The ...
- Combined Gene Therapy Shows Promise, but Not Synergy, in Miceon December 1, 2021 at 4:19 am
A combined gene therapy that delivered two nerve growth factors — NRG1-I and NRG1-III — to muscle and nerve cells improved motor function and delayed disease onset in a mouse model of amyotrophic ...
- Mechanisms for mitochondrial-targeted cancer therapy detectedon November 30, 2021 at 5:14 am
In a recent study published in the scientific journal EMBO Reports, the Nils-Göran Larsson group has identified responses to acute and chronic impairment of mitochondrial gene expression. These ...
Go deeper with Google Headlines on:
Gene therapy pathway
Go deeper with Bing News on:
- Parents of Grand Forks girl fighting rare disease push for FDA approval of gene therapy that could save her lifeon December 4, 2021 at 1:00 pm
Daphne Enger, 6, has been battling a rare brain disease that has caused her to lose her motor skills and speech. Her parents hope a petition drive will persuade the FDA to fast track a gene therapy ...
- Gene therapy startup bursts forth from incubation at J&J and F-Prime, graduating with $80M and a Novartis veteran at the helmon December 3, 2021 at 4:25 am
AviadoBio has come flying out the traps surrounded by A-list names. Incubated at F-Prime Capital and Johnson & Johnson’s JJDC, AviadoBio exited stealth with $80 million from backers such as New ...
- Astellas Hopes to Improve Gene Therapy Safety with $1.6 Billion Dyno Dealon December 2, 2021 at 9:14 am
Gene therapy biotech Astellas is turning to Dyno Therapeutics to make their treatments safer. With a massive potential value, a lot rides on the deal, especially for Astellas. The Japanese pharma has ...
- What To Expect From Cell Therapy And Gene Therapy In 2022 And Beyondon November 30, 2021 at 10:38 pm
From innovations in clinical development and manufacturing to the evaluation of investigational cell and gene therapies (CGTs), subject matter experts from Cellectis and Immatics share a brief look ...
- Cell and Gene Therapy Sector Needs CMC Clarityon November 30, 2021 at 7:00 am
For therapeutic proteins and monoclonal antibody- (mAb) based medicines, CMC requirements are well established. And more importantly developers know what reviewers look for and, to a greater or lesser ...